We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$33.1B
AUM Growth
+$4.67B
Cap. Flow
+$3.45B
Cap. Flow %
10.43%
Top 10 Hldgs %
27.18%
Holding
755
New
214
Increased
168
Reduced
159
Closed
177

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$966M
2
AAPL icon
Apple
AAPL
+$767M
3
AMZN icon
Amazon
AMZN
+$706M
4
CRM icon
Salesforce
CRM
+$465M
5
NVDA icon
NVIDIA
NVDA
+$401M

Sector Composition

Rank Sector Weight
1 Technology 23.68%
2 Consumer Discretionary 13.65%
3 Industrials 9.63%
4 Healthcare 8.71%
5 Real Estate 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAEP
501
DELISTED
Cantor Equity Partners III
CAEP
$2.58M 0.01%
250,000
IMTX icon
502
Immatics
IMTX
$1.34B
$2.56M 0.01%
+300,000
New +$1.85M
AVR
503
Anteris Technologies
AVR
$886M
$2.48M 0.01%
550,000
WFC icon
504
Wells Fargo
WFC
$267B
$2.46M 0.01%
29,315
-189,485
-87% -$15.4M
FRGE
505
DELISTED
Forge Global Holdings
FRGE
$2.45M 0.01%
144,821
-65,207
-31% -$1.21M
ELUT icon
506
Elutia
ELUT
$38.4M
$2.35M 0.01%
2,643,445
QURE icon
507
uniQure
QURE
$3.16B
$2.33M 0.01%
+40,000
New +$726K
OCS icon
508
Oculis Holding
OCS
$695M
$2.31M 0.01%
131,332
VNO icon
509
Vornado Realty Trust
VNO
$7.26B
$2.22M 0.01%
+54,713
New +$2.13M
HPP
510
Hudson Pacific Properties
HPP
$746M
$2.07M 0.01%
107,143
-786,017
-88% -$14.8M
SPGI icon
511
S&P Global
SPGI
$121B
$1.94M 0.01%
+3,995
New +$2.14M
VOXR
512
Vox Royalty Corp
VOXR
$350M
$1.83M 0.01%
+425,000
New +$1.46M
SKYE icon
513
Skye Bioscience
SKYE
$18.7M
$1.79M 0.01%
456,163
XAIR icon
514
Beyond Air
XAIR
$3.78M
$1.75M 0.01%
+37,953
New +$2.11M
URG
515
Ur-Energy
URG
$572M
$1.71M 0.01%
954,894
-500,000
-34% -$678K
PIII icon
516
P3 Health Partners
PIII
$41.1M
$1.62M ﹤0.01%
180,906
URBN icon
517
Urban Outfitters
URBN
$6.61B
$1.61M ﹤0.01%
+22,572
New +$1.66M
CNTX icon
518
Context Therapeutics
CNTX
$42.9M
$1.61M ﹤0.01%
1,663,355
ABOS icon
519
Acumen Pharmaceuticals
ABOS
$176M
$1.61M ﹤0.01%
939,603
BXP icon
520
Boston Properties
BXP
$10.9B
$1.61M ﹤0.01%
+21,601
New +$1.52M
DGXX
521
Digi Power X Inc
DGXX
$372M
$1.58M ﹤0.01%
+692,016
New +$1.86M
EPRX
522
Eupraxia Pharmaceuticals
EPRX
$436M
$1.48M ﹤0.01%
+250,000
New +$1.36M
SWK icon
523
Stanley Black & Decker
SWK
$15.6B
$1.45M ﹤0.01%
+19,545
New +$1.43M
COGT icon
524
Cogent Biosciences
COGT
$6.82B
$1.44M ﹤0.01%
+100,000
New +$1.18M
BRCB
525
Black Rock Coffee Bar Inc
BRCB
$157M
$1.43M ﹤0.01%
+60,000
New +$1.57M

Similar funds

Alyeska Investment Group's Q3 2025 Portfolio in Review

As of Q3 2025, Alyeska Investment Group held 755 positions worth $33.1B, up 16% from $28.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Alyeska Investment Group deployed $3.45B of net new capital in Q3 2025, opening 214 new positions and adding to 168 existing holdings. Its largest new stake was Tesla: 804,280 shares worth $358M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $379M trimmed.

  • Alyeska Investment Group's largest Q3 2025 buy was Tesla: 804,280 shares worth $358M.
  • Alyeska Investment Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $966M increase.
  • Alyeska Investment Group's biggest Q3 2025 reduction was JPMorgan Chase, cutting an estimated $379M.
  • Alyeska Investment Group fully exited Wayfair in Q3 2025, selling an estimated $298M.
  • Alyeska Investment Group's ten largest holdings make up 27% of its $33.1B portfolio in Q3 2025.
  • Alyeska Investment Group opened 214 new positions and closed 177 in Q3 2025.
  • Alyeska Investment Group's portfolio value rose 16% quarter-over-quarter to $33.1B.

Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.